PortalPublikationenExtrakorporale Therapien bei Patienten mit Lebererkrankungen...

Extrakorporale Therapien bei Patienten mit Lebererkrankungen auf der Intensivstation

Standard

Extrakorporale Therapien bei Patienten mit Lebererkrankungen auf der Intensivstation. / Fuhrmann, V; Horvatits, T; Drolz, A; Rutter, Karoline.

in: MED KLIN-INTENSIVMED, Jahrgang 109, Nr. 4, 01.05.2014, S. 246-51.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Fuhrmann, V, Horvatits, T, Drolz, A & Rutter, K 2014, 'Extrakorporale Therapien bei Patienten mit Lebererkrankungen auf der Intensivstation', MED KLIN-INTENSIVMED, Jg. 109, Nr. 4, S. 246-51. https://doi.org/10.1007/s00063-013-0321-4

APA

Fuhrmann, V., Horvatits, T., Drolz, A., & Rutter, K. (2014). Extrakorporale Therapien bei Patienten mit Lebererkrankungen auf der Intensivstation. MED KLIN-INTENSIVMED, 109(4), 246-51. https://doi.org/10.1007/s00063-013-0321-4

Vancouver

Fuhrmann V, Horvatits T, Drolz A, Rutter K. Extrakorporale Therapien bei Patienten mit Lebererkrankungen auf der Intensivstation. MED KLIN-INTENSIVMED. 2014 Mai 1;109(4):246-51. https://doi.org/10.1007/s00063-013-0321-4

Bibtex

@article{83e0388f2bb6420fa8d12ddcaf4280e2,
title = "Extrakorporale Therapien bei Patienten mit Lebererkrankungen auf der Intensivstation",
abstract = "Acute and acute-on-chronic liver failure are often associated with development of organ failure. Its occurrence is associated with high morbidity and mortality. Extracorporeal replacement therapies are frequently necessary in these patient populations. Replacement therapies can be divided into renal replacement therapies and liver support therapies. These therapies consist of artificial liver support systems (i.e., MARS({\textregistered}) system, Prometheus({\textregistered})), which are able to remove water-soluble and albumin-bound toxins, and of bioartifical liver support systems. This manuscript provides a review of current practice in the extracorporeal support of patients with liver diseases in the intensive care unit.",
author = "V Fuhrmann and T Horvatits and A Drolz and Karoline Rutter",
year = "2014",
month = may,
day = "1",
doi = "10.1007/s00063-013-0321-4",
language = "Deutsch",
volume = "109",
pages = "246--51",
journal = "MED KLIN-INTENSIVMED",
issn = "2193-6218",
publisher = "Springer Medizin",
number = "4",

}

RIS

TY - JOUR

T1 - Extrakorporale Therapien bei Patienten mit Lebererkrankungen auf der Intensivstation

AU - Fuhrmann, V

AU - Horvatits, T

AU - Drolz, A

AU - Rutter, Karoline

PY - 2014/5/1

Y1 - 2014/5/1

N2 - Acute and acute-on-chronic liver failure are often associated with development of organ failure. Its occurrence is associated with high morbidity and mortality. Extracorporeal replacement therapies are frequently necessary in these patient populations. Replacement therapies can be divided into renal replacement therapies and liver support therapies. These therapies consist of artificial liver support systems (i.e., MARS(®) system, Prometheus(®)), which are able to remove water-soluble and albumin-bound toxins, and of bioartifical liver support systems. This manuscript provides a review of current practice in the extracorporeal support of patients with liver diseases in the intensive care unit.

AB - Acute and acute-on-chronic liver failure are often associated with development of organ failure. Its occurrence is associated with high morbidity and mortality. Extracorporeal replacement therapies are frequently necessary in these patient populations. Replacement therapies can be divided into renal replacement therapies and liver support therapies. These therapies consist of artificial liver support systems (i.e., MARS(®) system, Prometheus(®)), which are able to remove water-soluble and albumin-bound toxins, and of bioartifical liver support systems. This manuscript provides a review of current practice in the extracorporeal support of patients with liver diseases in the intensive care unit.

U2 - 10.1007/s00063-013-0321-4

DO - 10.1007/s00063-013-0321-4

M3 - SCORING: Zeitschriftenaufsatz

C2 - 24770889

VL - 109

SP - 246

EP - 251

JO - MED KLIN-INTENSIVMED

JF - MED KLIN-INTENSIVMED

SN - 2193-6218

IS - 4

ER -